|
2,628
|
| 28998 |
HSC (Tie2+SP,KSL)
|
|
increases_expression of
|
Cdh2
|
|
|
| 28999 |
osteoblast (osteocalcin+)
|
|
increases_expression of
|
Cdh2
|
in comparison to LT-HSC (Tie2+SP,KSL)
|
|
| 29001 |
Angpt1
|
|
increases_expression of
|
Cdh2
|
in LT-HSC (Tie2+SP,KSL)
|
|
| 29003 |
Tie2/Ang1 signaling
|
|
increases_expression of
|
Cdh2
|
in LT-HSC (Tie2+SP,KSL)
|
|
|
15260986
|
|
2,756
|
| 25507 |
SNO cell (N-cadherin+CD45-)
|
|
increases_quantity of
|
Cdh2
|
|
in vivo
|
| 26923 |
Cdh2
|
|
interacts (colocalizes) with
|
Ctnnb1
|
|
|
| 37280 |
HSC (N-cadherin+CD45+KSL)
|
|
increases_quantity of
|
Cdh2
|
|
in vivo
|
|
14574412
|
|
2,830
|
| 26138 |
osteoblast (N-cadherin+)
|
|
increases_quantity of
|
Cdh2
|
|
|
|
19052548
|
|
2,856
|
| 26359 |
osteoblast-enriched cell (Alcam+Sca1-)
|
|
increases_expression of
|
Cdh2
|
|
|
|
20472830
|
|
2,878
|
| 26522 |
osteoblast
|
|
increases_expression of
|
Cdh2
|
in Wif1-overexpressing osteoblasts. Expression is down-regulated after 5-FU-treatment
|
in vivo
|
| 26546 |
Wif1
|
|
increases_expression of
|
Cdh2
|
in Wif1-overexpressing osteoblasts. Expression is down-regulated after 5-FU-treatment
|
in vivo
|
|
21652676
|
|
3,010
|
| 27449 |
HSC (CD34-KSL)
|
|
decreases_quantity of
|
Cdh2
|
The surface marker is only expressed on CD34+KSL cells
|
|
|
20421392
|
|
3,117
|
| 28693 |
osteoblastic bone-lining cell (CD45-Ter119-CD31-)
|
|
increases_quantity of
|
Cdh2
|
|
|
| 28694 |
RelB/NF-kappaB signaling
|
|
increases_quantity of
|
Cdh2
|
in osteoblastic bone-lining cell (CD45-Ter119-CD31-); of RelB/Nfkb2 double knockout mice
|
|
| 28695 |
Relb
|
|
increases_quantity of
|
Cdh2
|
in osteoblastic bone-lining cell (CD45-Ter119-CD31-); of RelB/Nfkb2 double knockout mice
|
|
| 28696 |
Nfkb2
|
|
increases_quantity of
|
Cdh2
|
in osteoblastic bone-lining cell (CD45-Ter119-CD31-); of RelB/Nfkb2 double knockout mice
|
|
|
22290873
|
|
3,132
|
| 28863 |
SNO cell (N-cadherin+CD45-)
|
|
increases_quantity of
|
Cdh2
|
in c-Myc-deficient mice
|
in vivo
|
| 28865 |
HSC (KSL)
|
|
increases_quantity of
|
Cdh2
|
in c-Myc-deficient mice
|
in vivo
|
| 28866 |
Myc
|
|
decreases_quantity of
|
Cdh2
|
|
in vivo
|
| 29408 |
Cdh2
|
|
interacts (colocalizes) with
|
Cdh2
|
|
|
|
15545632
|
|
3,158
|
| 29053 |
Wnt3a
|
|
increases_expression of
|
Cdh2
|
in stromal cells
|
|
|
18951693
|
|
3,198
|
| 29369 |
Cdh2
|
NOT |
affects_activity of
|
repopulation >16 weeks
|
of HSC (CD150+CD48-CD41-KSL)
|
in vivo
|
|
18371351
|
|
3,201
|
| 29386 |
HSC (CD34+KSL)
|
|
decreases_expression of
|
Cdh2
|
in comparison to LT-HSC (CD34-KSL) cells
|
|
| 29392 |
HSC (CD34-KSL)
|
|
increases_expression of
|
Cdh2
|
in comparison to ST-HSC (CD34+KSL) cells
|
|
| 29396 |
osteoblast-enriched cell (Alcam+Sca1-)
|
|
increases_expression of
|
Cdh2
|
compared to ALCAM-Sca1- and ALCAM-Sca1+ endosteal BMCs
|
|
| 29404 |
Cdh2
|
|
increases_activity of
|
cell adhesion
|
of HSC (KSL) cells to the endosteal surface, but has no effect on HSC homing
|
in vivo
|
| 29406 |
Cdh2
|
|
increases_activity of
|
repopulation >16 weeks
|
of HSC (KSL) cells but has no effect on HSC homing
|
in vivo
|
| 29411 |
Cdh2
|
|
decreases_activity of
|
cell cycle
|
of HSC (KSL) or HSC (SP,KSL)
|
in vitro
|
| 29412 |
Cdh2
|
|
increases_activity of
|
quiescence
|
of HSC (KSL) or HSC (SP,KSL)
|
in vitro
|
| 29413 |
Cdh2
|
|
increases_activity of
|
self-renewal
|
of HSC (KSL)
|
in vivo
|
| 38821 |
Cdh2
|
|
increases_activity of
|
self-renewal
|
together with beta-catenin
|
in vivo
|
| 38823 |
Cdh2
|
|
interacts (colocalizes) with
|
Ctnnb1
|
|
in vivo
|
|
20207221
|
|
3,241
|
| 29915 |
HSC (KSL)
|
|
increases_expression of
|
Cdh2
|
if cocultured with the endosteal cell fraction (ALCAM+Sca1-)
|
|
|
20472830
|
|
3,574
|
| 33460 |
HSC (CD34-CD150+KSL)
|
|
increases_expression of
|
Cdh2
|
|
|
| 33462 |
osteoblast-enriched cell (Alcam+Sca1-)
|
|
increases_expression of
|
Cdh2
|
|
|
| 33499 |
Cdh2
|
|
increases_activity of
|
self-renewal
|
|
in vivo
|
| 33500 |
Cdh2
|
|
increases_activity of
|
self-renewal
|
|
in vivo
|
| 33501 |
Cdh2
|
|
interacts (colocalizes) with
|
Ctnnb1
|
interaction is necessary for high self-renewal capacity
|
|
| 33502 |
Cdh2
|
|
increases_activity of
|
cell adhesion
|
in the BM, but not in the spleen
|
in vivo
|
|
22901259
|
|
3,800
|
| 37755 |
HSC (CD135-KSL)
|
|
increases_expression of
|
Cdh2
|
|
|
| 37761 |
HSC (SP,KSL)
|
|
increases_expression of
|
Cdh2
|
|
|
| 37772 |
Reactive oxygen species
|
|
decreases_quantity of
|
Cdh2
|
in HSC (KSL)
|
in vitro
|
| 37782 |
HSC (N-cadherin+c-Kit)
|
|
increases_quantity of
|
Cdh2
|
|
|
| 37783 |
endosteal cell (N-cadherin+)
|
|
increases_quantity of
|
Cdh2
|
|
|
|
17897629
|
|
3,826
|
| 38303 |
Fancg
|
|
increases_expression of
|
Cdh2
|
In Fancg-/- KSL cells expression of N-cadherin is down-regulated.
|
|
| 38315 |
HSC (KSL)
|
|
increases_expression of
|
Cdh2
|
|
|
|
21968513
|
|
3,860
|
| 38792 |
Angpt1
|
|
increases_expression of
|
Cdh2
|
in HSC (KSL), if Angpt1 is overexpressed in osteoblasts
|
|
|
23149415
|
|
4,035
|
| 41666 |
osteoblastic cell (ELBO)
|
|
increases_expression of
|
Cdh2
|
compared to whole BM
|
|
|
22827607
|
HSC